导读
- 淋巴上皮瘤样(LEL)亚型尿路上皮癌:合体样生长伴混杂炎症;纯型时预后可较好且可能对化疗有反应。
- 与鼻咽淋巴上皮瘤样癌不同,尿路上皮 LEL 亚型与 EBV 无关;分子上常呈基底样表型。
- 镜下鉴别:淋巴瘤、小细胞癌、良性炎症——合体样上皮巢 + 合适 IHC 是关键。
- 本站收录 @slusagar 公开教学帖要点与 4 张 HE 附图(原帖无图注,图注按所见简述)。
收录范围:作者 X 公开帖文字要点中英对照,以及帖内 4 张 HE 附图。非期刊论著全文。
教学要点
Ankur Sangoi(@slusagar)于 2026-11-07 发帖,归纳淋巴上皮瘤样亚型尿路上皮癌(#GUpath)要点:
- 镜下:合体样(syncytial)生长 + 混杂炎症。
- 预后/治疗:尤其当成分为纯型时,预后可较好,且可能对化疗有反应。
- 病因:与 EBV 无关(不同于经典鼻咽淋巴上皮瘤样癌)。
- 分子:常呈基底样(basal-like)分子表型。
- 鉴别诊断:淋巴瘤、小细胞癌、良性炎症。
附图
原帖附 4 张 HE 图,未给图注;以下图注按图像所见简述。




In brief
- Lymphoepithelioma-like (LEL) subtype urothelial carcinoma: syncytial growth with admixed inflammation; pure forms may have favorable prognosis and chemo response.
- Unlike nasopharyngeal LEL carcinoma, the urothelial LEL subtype is not EBV-related and often shows a basal-like molecular phenotype.
- DDx: lymphoma, small cell carcinoma, benign inflammation — syncytial epithelial nests plus appropriate IHC are key.
- This post captures @slusagar's public teaching tip and four H&E images (no legends in the original post; captions briefly describe what is shown).
Scope: bilingual rendering of the author's public X teaching tip, plus the four attached H&E images. Not a journal full-text article.
Teaching points
Ankur Sangoi (@slusagar) posted on 2026-11-07 with these #GUpath tips on the lymphoepithelioma-like subtype of urothelial carcinoma:
- Morphology: syncytial growth + admixed inflammation.
- Prognosis/therapy: may show favorable prognosis (especially when pure) and respond to chemotherapy.
- Etiology: not related to EBV.
- Molecular: basal-like molecular phenotype.
- Differential diagnosis: lymphoma, small cell carcinoma, benign inflammation.
Images
Four H&E images were attached; no legends were provided. Captions below briefly describe what is shown.



